Matches in SemOpenAlex for { <https://semopenalex.org/work/W2079353112> ?p ?o ?g. }
Showing items 1 to 76 of
76
with 100 items per page.
- W2079353112 endingPage "299" @default.
- W2079353112 startingPage "299" @default.
- W2079353112 abstract "To assess the survival time of patients with HCC following transarterial chemoembolization performed in a highly selective and sequential way.124 HCC patients (102 male, 22 female; mean age 63 ± 11 years) treated with selective and sequential chemoembolization at a single center were included. Selective chemoembolization was performed through a coaxially introduced microcatheter in a segmental or subsegmental hepatic artery. Treatment was stopped after complete stasis of the blood flow in the tumor-feeding vessel. The primary endpoint of the study was overall survival.The median overall survival of the entire patient population was 27.2 months (mo) (±8.9 mo, 95% CI 9.8 mo, 44.6 mo). When stratified according to liver function the median survival was 46.1 mo (±9.0 mo; 95% CI 28.5 mo, 63.7 mo) for Child-Pugh A and 11.1 mo (±4.3 mo; 95% CI 2.7 mo, 19.5 mo) for Child-Pugh B (p < .001). The median survival was 46.1 mo (±16.6 mo; 95% CI 13.5 mo, 78.7 mo) for BCLC stage A, 19.7 mo (±2.6 mo; 95% CI 14.6 mo, 24.8 mo) for BCLC stage B, and 14.4 mo (±5.0 mo; 95% CI 4.5 mo, 24.3 mo) for BCLC stage C (p < .01).Selective and sequential chemoembolization offers long survival times in patients with HCC. Those patients with preserved liver function benefit more than patients with limited liver reserve." @default.
- W2079353112 created "2016-06-24" @default.
- W2079353112 creator A5019086869 @default.
- W2079353112 creator A5022702970 @default.
- W2079353112 creator A5038603211 @default.
- W2079353112 creator A5042784431 @default.
- W2079353112 creator A5043616693 @default.
- W2079353112 creator A5045667939 @default.
- W2079353112 creator A5059367996 @default.
- W2079353112 creator A5061157288 @default.
- W2079353112 creator A5078851457 @default.
- W2079353112 creator A5082944210 @default.
- W2079353112 date "2007-09-01" @default.
- W2079353112 modified "2023-09-25" @default.
- W2079353112 title "4502 ORAL Phase 2 study of irinotecan and cisplatin in epidermoid carcinoma of the penis (EORTC 30992)" @default.
- W2079353112 doi "https://doi.org/10.1016/s1359-6349(07)71133-3" @default.
- W2079353112 hasPublicationYear "2007" @default.
- W2079353112 type Work @default.
- W2079353112 sameAs 2079353112 @default.
- W2079353112 citedByCount "0" @default.
- W2079353112 crossrefType "journal-article" @default.
- W2079353112 hasAuthorship W2079353112A5019086869 @default.
- W2079353112 hasAuthorship W2079353112A5022702970 @default.
- W2079353112 hasAuthorship W2079353112A5038603211 @default.
- W2079353112 hasAuthorship W2079353112A5042784431 @default.
- W2079353112 hasAuthorship W2079353112A5043616693 @default.
- W2079353112 hasAuthorship W2079353112A5045667939 @default.
- W2079353112 hasAuthorship W2079353112A5059367996 @default.
- W2079353112 hasAuthorship W2079353112A5061157288 @default.
- W2079353112 hasAuthorship W2079353112A5078851457 @default.
- W2079353112 hasAuthorship W2079353112A5082944210 @default.
- W2079353112 hasConcept C126322002 @default.
- W2079353112 hasConcept C141071460 @default.
- W2079353112 hasConcept C146357865 @default.
- W2079353112 hasConcept C151730666 @default.
- W2079353112 hasConcept C2778019345 @default.
- W2079353112 hasConcept C2778455285 @default.
- W2079353112 hasConcept C2908647359 @default.
- W2079353112 hasConcept C2992208098 @default.
- W2079353112 hasConcept C71924100 @default.
- W2079353112 hasConcept C86803240 @default.
- W2079353112 hasConcept C90924648 @default.
- W2079353112 hasConcept C99454951 @default.
- W2079353112 hasConceptScore W2079353112C126322002 @default.
- W2079353112 hasConceptScore W2079353112C141071460 @default.
- W2079353112 hasConceptScore W2079353112C146357865 @default.
- W2079353112 hasConceptScore W2079353112C151730666 @default.
- W2079353112 hasConceptScore W2079353112C2778019345 @default.
- W2079353112 hasConceptScore W2079353112C2778455285 @default.
- W2079353112 hasConceptScore W2079353112C2908647359 @default.
- W2079353112 hasConceptScore W2079353112C2992208098 @default.
- W2079353112 hasConceptScore W2079353112C71924100 @default.
- W2079353112 hasConceptScore W2079353112C86803240 @default.
- W2079353112 hasConceptScore W2079353112C90924648 @default.
- W2079353112 hasConceptScore W2079353112C99454951 @default.
- W2079353112 hasIssue "4" @default.
- W2079353112 hasLocation W20793531121 @default.
- W2079353112 hasOpenAccess W2079353112 @default.
- W2079353112 hasPrimaryLocation W20793531121 @default.
- W2079353112 hasRelatedWork W2141896878 @default.
- W2079353112 hasRelatedWork W2347335137 @default.
- W2079353112 hasRelatedWork W2358577523 @default.
- W2079353112 hasRelatedWork W2396739986 @default.
- W2079353112 hasRelatedWork W2398516763 @default.
- W2079353112 hasRelatedWork W2803786348 @default.
- W2079353112 hasRelatedWork W3025490003 @default.
- W2079353112 hasRelatedWork W3031610734 @default.
- W2079353112 hasRelatedWork W4287073673 @default.
- W2079353112 hasRelatedWork W4317038016 @default.
- W2079353112 hasVolume "5" @default.
- W2079353112 isParatext "false" @default.
- W2079353112 isRetracted "false" @default.
- W2079353112 magId "2079353112" @default.
- W2079353112 workType "article" @default.